Our study investigated the nuances of the InImS in IBD and its novel biomarkers, FERAD, FEREFF, and p87, and provided some justification for the inclusion of ferritin in the FERAD ratio, which would not have been apparent due to the “common wisdom”. This evidence concerns the gene IMMT and inflammatory bowel disease.